v3.25.0.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Net revenue      
Total net revenue $ 693,398 $ 531,822 $ 320,668
Cost and operating expenses      
Technology research and development 167,519 95,155 79,093
Research and development 149,325 90,343 83,158
Selling, general and administrative 755,351 296,760 233,377
Total cost and operating expenses 1,384,480 727,905 586,110
Loss from operations (691,082) (196,083) (265,442)
Interest income 11,084 7,601 3,032
Interest expense (53,653) (46,869) (21,894)
Other income, net 32,336 21,822 (4,846)
Loss before provision for income taxes (701,315) (213,529) (289,150)
Provision for income taxes (266) (288) (66)
Losses from equity method investments (4,228) (301) (595)
Net Loss (705,809) (214,118) (289,811)
Accretion of convertible preferred stock to redemption value 0 (4,338) (301)
Dividends on Series A, B, B-1, B-2, C, D, E, F, G, G-3, and G-4 preferred shares (39,347) (44,497) (40,975)
Cumulative undeclared dividends on Series C preferred shares (1,174) (3,011) (2,841)
Net loss attributable to common shareholders, basic (746,330) (265,964) (333,928)
Net loss attributable to common shareholders, diluted $ (746,330) $ (265,964) $ (333,928)
Net loss per share attributable to common shareholders, basic $ (6.23) $ (4.2) $ (5.3)
Net loss per share attributable to common shareholders, diluted $ (6.23) $ (4.2) $ (5.3)
Weighted-average shares outstanding used to compute net loss per share, basic 119,849 63,306 63,032
Weighted-average shares outstanding used to compute net loss per share, diluted 119,849 63,306 63,032
Comprehensive Loss, net of tax      
Net loss $ (705,809) $ (214,118) $ (289,811)
Foreign currency translation adjustment 89 (13) 29
Comprehensive loss (705,720) (214,131) (289,782)
Genomics [Member]      
Net revenue      
Total net revenue 451,749 363,022 197,984
Cost and operating expenses      
Cost of revenues 243,467 189,165 150,255
Data and Services [Member]      
Net revenue      
Total net revenue 241,649 168,800 122,684
Cost and operating expenses      
Cost of revenues $ 68,818 $ 56,482 $ 40,227